Gain Therapeutics Income Statement (2020-2025) | GANX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) 0.01M0.01M0.01M0.01M0.01M0.08M0.03M0.04M0.05M0.10M0.06M
Operating items
Research & Development (Quarter) 0.42M0.44M0.43M0.98M1.42M1.79M2.48M1.47M1.56M2.58M1.96M2.27M2.79M3.99M2.37M2.37M2.51M4.44M2.62M1.22M2.26M2.76M2.85M2.35M
Selling, General & Administrative (Quarter) 0.10M0.10M0.40M0.65M1.05M1.81M2.19M1.78M1.78M2.69M2.79M2.29M2.49M3.74M2.52M2.03M1.87M3.75M1.84M2.11M2.11M2.33M1.94M2.12M
Operating Expenses (Quarter) 0.52M0.54M0.83M1.62M2.47M3.60M4.66M3.25M3.33M5.27M4.75M4.56M5.28M7.73M4.89M4.41M4.38M8.18M4.46M3.33M4.37M5.09M4.79M4.47M
Operating Income (Quarter) -0.51M-0.53M-0.82M-1.62M-2.47M-3.51M-4.64M-3.21M-3.29M-5.18M-4.75M-4.56M-5.23M-7.73M-4.89M-4.41M-4.38M-8.18M-4.46M-3.33M-4.37M-5.09M-4.79M10.19M
EBIT (Quarter) -0.51M-0.53M-0.82M-1.62M-2.47M-3.51M-4.64M-3.21M-3.29M-5.18M-4.75M-4.56M-5.23M-7.73M-4.89M-4.41M-4.38M-8.18M-4.46M-3.33M-4.37M-5.09M-4.79M10.19M
Non-operating items
Interest & Investment Income (Quarter) 0.12M0.08M0.11M0.05M0.04M0.04M0.08M0.08M
Other Non Operating Income (Quarter) -0.07M-0.00M0.03M-0.05M0.02M-0.04M-0.03M-0.02M0.02M0.04M0.04M-0.20M-0.04M-0.06M0.08M-0.41M0.27M-0.04M-0.12M0.02M-0.10M-0.62M-0.03M-0.08M
Net income details
EBT (Quarter) -0.58M-0.54M-0.79M-1.66M-2.45M-3.55M-4.66M3.06M-3.27M-5.08M-4.55M12.75M-5.12M-7.66M-4.70M-4.71M-3.99M-8.14M-4.47M-3.26M-4.43M-5.67M-4.74M18.01M
Tax Provisions (Quarter) 0.00M0.00M885.00-0.00M0.00M0.00M0.01M-0.01M0.00M0.01M0.00M0.08M0.02M0.03M0.02M0.01M0.02M0.00M0.01M0.50M0.10M0.14M0.55M0.07M
Profit After Tax (Quarter) -0.58M-0.54M-0.79M-1.66M-2.45M-3.56M-4.66M-3.22M-3.27M-5.09M-4.56M-4.67M-5.14M-7.69M-4.72M-4.72M-4.01M-8.14M-4.49M-3.77M-4.53M-5.81M-5.28M-4.54M
Income from Continuing Operations (Quarter) -0.58M-0.54M-0.79M-1.66M-2.45M-3.56M-4.66M3.07M-3.27M-5.09M-4.56M12.67M-5.14M-7.69M-4.72M-4.72M-4.01M-8.14M-4.49M-3.77M-4.53M-5.81M-5.28M17.94M
Consolidated Net Income (Quarter) -0.58M-0.54M-0.79M-1.66M-2.45M-3.56M-4.66M3.07M-3.27M-5.09M-4.56M12.67M-5.14M-7.69M-4.72M-4.72M-4.01M-8.14M-4.49M-3.77M-4.53M-5.81M-5.28M17.94M
Income towards Parent Company (Quarter) -0.58M-0.54M-0.79M-1.66M-2.45M-3.56M-4.66M3.07M-3.27M-5.09M-4.56M12.67M-5.14M-7.69M-4.72M-4.72M-4.01M-8.14M-4.49M-3.77M-4.53M-5.81M-5.28M17.94M
Net Income towards Common Stockholders (Quarter) -0.58M-0.54M-0.79M-1.66M-2.45M-3.56M-4.66M3.07M-3.27M-5.09M-4.56M12.67M-5.14M-7.69M-4.72M-4.72M-4.01M-8.14M-4.49M-3.77M-4.53M-5.81M-5.28M17.94M
Additional items
EPS (Basic) (Quarter) -0.29-0.27-0.25-0.53-0.50-0.30-0.39-0.26-0.28-0.43-0.38-0.39-0.43-0.62-0.37-0.29-0.22-0.42-0.17-0.11-0.16-0.19-0.15-0.11
EPS (Weighted Average and Diluted) (Quarter) -0.27-0.25-0.53-0.50-0.30-0.39-0.26-0.28-0.43-0.38-0.39-0.43-0.62-0.37-0.29-0.22-0.42-0.17-0.11-0.16-0.19-0.15-0.11
Shares Outstanding (Weighted Average) (Quarter) 1.98M1.98M2.39M2.68M4.87M11.88M11.88M10.17M11.88M11.88M11.88M11.88M11.94M12.16M12.70M13.01M17.98M18.60M26.53M6.14M5.68M30.34M31.35M
Shares Outstanding (Diluted Average) (Quarter) 1.98M2.39M2.68M4.87M8.43M11.88M10.17M11.88M11.88M11.88M11.88M11.94M12.39M12.70M13.01M17.98M19.22M26.53M22.88M28.69M30.34M31.35M
EBITDA (Quarter) -0.51M-0.53M-0.82M-1.62M-2.47M-3.51M-4.64M-3.21M-3.29M-5.18M-4.75M-4.56M-5.23M-7.73M-4.89M-4.41M-4.38M-8.18M-4.46M-3.33M-4.37M-5.09M-4.79M10.19M
Shares Outstanding (Quarter) 1.98M1.98M1.19M2.97M11.88M11.88M11.88M11.88M11.88M11.88M11.88M11.88M12.09M12.63M12.78M16.21M18.04M25.17M25.96M27.13M28.75M30.77M35.98M
Tax Rate (Quarter) -0.23-0.84-0.110.08-0.14-0.10-0.11-0.27-0.05-0.18-0.090.61-0.33-0.35-0.46-0.31-0.50-0.01-0.25-15.47-2.27-2.49-11.600.39